Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors

Bioorganic & Medicinal Chemistry
2007.0

Abstract

In our ongoing program aimed at the design, synthesis, and biological evaluation of novel cannabinoid receptor ligands derived from olivetol and hexyl-resorcinol, we have designed a structural model for new derivatives on the basis of a previous study. Here we report the synthesis, binding, and molecular modeling studies of new potent compounds with high affinity toward CB(1) and CB(2) receptors. Compounds with amidic 'heads' with alkyloxy chains varying in length from 8 to 12 carbon atoms showed nanomolar affinity for both receptors, depending on the type of aromatic backbone. Two of the new compounds, although not very potent, exhibit selectivity for CB(1) receptors (CB(1)/CB(2)=0.07 and 0.08, respectively). Molecular modeling studies fitted this new class of cannabinoid ligands into a CB(1) receptor model, and the qualitative analysis of the results was in general agreement with the CB(1) affinity constants observed experimentally for these derivatives.

Knowledge Graph

Similar Paper

Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors
Bioorganic & Medicinal Chemistry 2007.0
Design, Synthesis, and Binding Studies of New Potent Ligands of Cannabinoid Receptors
Journal of Medicinal Chemistry 2005.0
Novel 4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New CB<sub>2</sub>Cannabinoid Receptors Agonists:  Synthesis, Pharmacological Properties and Molecular Modeling
Journal of Medicinal Chemistry 2006.0
New Resorcinol−Anandamide “Hybrids” as Potent Cannabinoid Receptor Ligands Endowed with Antinociceptive Activity in Vivo
Journal of Medicinal Chemistry 2009.0
Novel sterically hindered cannabinoid CB1 receptor ligands
Bioorganic &amp; Medicinal Chemistry 2008.0
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity
Bioorganic &amp; Medicinal Chemistry 2020.0
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists
Bioorganic &amp; Medicinal Chemistry Letters 2007.0
Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: Design, synthesis, structure–activity relationships, physicochemical properties and biological activity
European Journal of Medicinal Chemistry 2011.0
New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies
Bioorganic &amp; Medicinal Chemistry Letters 2006.0
Design, Synthesis, and Biological Evaluation of New 1,8-Naphthyridin-4(1H)-on-3-carboxamide and Quinolin-4(1H)-on-3-carboxamide Derivatives as CB<sub>2</sub>Selective Agonists
Journal of Medicinal Chemistry 2006.0